Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
GPCR News
Carola Weiss joins InterAx Biotech AG as VP Business Development
Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
Dr. Juan José Fung - Dr. GPCR Podcast
Mark Schmeizl - Dr. GPCR Podcast
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
Novo Nordisk moves to strengthen obesity efforts
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
Learn more about Neurocrine Biosciences with their new video
Verily links up with Sosei Heptares for GPCR drug discovery
ShouTi Pharma has a brand new website
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Drug Discovery Picks Up the Pace, Stays on Target
Learn more about Neurocrine Biosciences with their new video
Dr. Nicola J. Smith - Dr. GPCR Podcast
Targeted Therapies to Reduce Side Effects in Modern Drug Development
Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards